Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Synthesis AI, a synthetic data company, has released HumanAPI, a new tool ...

Syngene had successfully demonstrated the small-scale synthesis of a novel vascular calcification inhibitor API from lab-scale to tox-batch manufacturing. This was following the request of a pharma ...

Alibaba’s Tongyi Lab has introduced a new open-source training framework that can train open large language models (LLMs) to compete with leading commercial deep research models. The technique, called ...

Ludwigshafen, Germany – October 1, 2015 – BASF has completed the previously announced sale of its pharma custom synthesis business and parts of its active pharmaceutical ingredients (APIs) business to ...

Chemical process development bridges drug discovery and active pharmaceutical ingredient (API) manufacturing by enabling rapid, safe, sustainable, and cost-effective access to new chemical modalities.